A carregar...
Targeting a Common Collaborator in Cancer Development
In this issue of Science Translational Medicine, Wallin et al. have identified a subset of breast and ovarian cancer cell lines that show synergistic response to the combination of doxorubicin and GDC-0941, a class IA phosphatidylinositol 3-kinase (PI3K) inhibitor. Here, we discuss the potential imp...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3425950/ https://ncbi.nlm.nih.gov/pubmed/20826838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3001251 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|